Profil
Richard L.
Rudolph joined Cyberonics, Inc. in August 2001 as Vice President of Clinical, Regulatory and Medical Affairs and Chief Medical Officer.
He was Senior Director of Clinical Research and Development for Wyeth-Ayerst Research.
Anciens postes connus de Richard L. Rudolph
| Sociétés | Poste | Fin |
|---|---|---|
| CYBERONICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2008 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |